April 11, 2025
Harvard Bioscience Announces CFO Transition
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
April 11, 2025
Arcutis Announces Chief Financial Officer Transition
Latha Vairavan Latha Vairavan, currently vice president and controller, will assume the role of CFO and join the executive team.…
April 11, 2025
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) — Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes…
April 11, 2025
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…
April 10, 2025
Genflow launches new development program in ophtamology, advancing its cSIRT6
Genflow Biosciences, the only publicly listed longevity company in Europe, has launched a new development program in ophthalmology, focused on…
April 10, 2025
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…
April 10, 2025
Codexis Announces Byron Dorgan to Retire from Board of Directors
REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for…
April 9, 2025
Valneva and LimmaTech vaccinate first participants in phase 2 infant study of tetravalent shigella vaccine candidate S4V2
Valneva SE, a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases,…
April 9, 2025
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
April 9, 2025
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company…